Diabetic Nephropathy Market by Treatment (Antihypertensive Drugs, Diuretics), Diagnostic Tool (Biomarker-based Tests, Imaging Techniques, Urinalysis), Indication (Type-1 Diabetes, Type-2 Diabetes), End-User (Hospital & Clinics, Surgical Centers) & Region for 2024-2031
Report ID: 41637|No. of Pages: 202
Diabetic Nephropathy Market by Treatment (Antihypertensive Drugs, Diuretics), Diagnostic Tool (Biomarker-based Tests, Imaging Techniques, Urinalysis), Indication (Type-1 Diabetes, Type-2 Diabetes), End-User (Hospital & Clinics, Surgical Centers) & Region for 2024-2031
Diabetic Nephropathy Market Valuation – 2024-2031
Diabetic nephropathy is a significant consequence of diabetes that impairs the kidneys’ ability to filter waste from the blood. The market for diabetic nephropathy treatments includes medications that target renal function and disease progression, as well as diagnostic instruments for early detection and monitoring. These factors are likely to enable the market size surpass USD 2.6 Billion valued in 2023 to reach a valuation of around USD 4.20 Billion by 2031.
In recent years, advances in biotechnology have fuelled the development of innovative medicines aimed at preventing kidney damage in diabetic patients. This market sees ongoing research into novel drug formulations and personalized medicine techniques, emphasizing the need for effective, patient-centered solutions to control and treat diabetic nephropathy. The rising demand for Diabetic Nephropathy is enabling the market grow at a CAGR of 5.4% from 2024 to 2031.
>>> Get | Download Sample Report @ – https://www.verifiedmarketresearch.com/download-sample/?rid=41637
Diabetic Nephropathy Market: Definition/ Overview
Diabetic nephropathy is diabetes-related kidney injury. It is characterized by increasing kidney function impairment caused by chronic high blood sugar levels, which can lead to problems such as proteinuria and, eventually, renal failure.
Diabetic nephropathy is kidney disease induced by diabetes. It is the main cause of kidney failure globally, characterized by proteinuria, hypertension and progressive reduction in kidney function. Management entails strict glucose control, blood pressure control and in some cases, kidney-protective medicines.
Diabetic Nephropathy is a major renal consequence of diabetes that causes gradual kidney damage and function loss. It is the main cause of end-stage renal disease worldwide, needing early detection and treatment to prevent long-term consequences.
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
What's inside a VMR
industry report?
>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=41637
Will Increasing Prevalence of Diabetes Drive the Diabetic Nephropathy Market?
The rising prevalence of diabetes is projected to drive the diabetic nephropathy market. Diabetes prevalence rises globally, particularly in Asia-Pacific and North America, as does the incidence of diabetic nephropathy. This kidney problem is a prominent consequence of diabetes, resulting in a higher need for diagnostic technologies, therapies and management techniques.
Healthcare systems and providers will be under increasing pressure to address the growing burden of diabetic nephropathy, resulting in a rise in research and development of new medicines and diagnostic tools. Furthermore, rising awareness of diabetes-related issues among patients and healthcare professionals can lead to earlier detection and intervention, hence encouraging market growth.
Overall, the rising diabetes epidemic highlights the need of developing solutions for diabetic nephropathy, positioning the market for significant growth as it strives to meet the healthcare needs of a growing patient population.
Will Lack of Awareness About the Disease Among General Population Hamper the Diabetic Nephropathy Market?
Lack of public understanding regarding diabetic nephropathy can stymie market growth. Individuals who lack appropriate expertise may fail to notice symptoms early on, resulting in a delayed diagnosis and treatment. This delay can lead to advanced disease stages and poorer patient outcomes.
Furthermore, low knowledge can result in decreasing demand for screening tests and preventative actions, limiting market growth for diagnostic tools and medicines. Healthcare practitioners may also have difficulty implementing effective illness management techniques without proactive patient engagement and education.
Addressing this awareness gap requires public health campaigns, education activities, and healthcare provider training. Better understanding can encourage early screening, promote better disease management practices, and assist the adoption of novel medicines, ultimately boosting the diabetic nephropathy market by improving patient outcomes and increasing market demand.
Category-Wise Acumens
Will Effectiveness in Managing Blood Pressure Drive the Antihypertensive Drugs Segment?
The effectiveness of blood pressure management will fuel the antihypertensive medicine market. Proper blood pressure management is critical in diabetic nephropathy, as high blood pressure hastens kidney damage. Antihypertensive medicines, particularly ACE inhibitors and ARBs, not only lower blood pressure but also preserve the kidneys by lowering proteinuria.
Their combined action of lowering hypertension and maintaining renal function makes them a popular choice among healthcare providers. Furthermore, these medications are well tolerated, widely available and frequently included in conventional treatment guidelines for diabetic nephropathy.
Continued research and development improve their efficacy and safety, increasing usage. Thus, the established effectiveness in blood pressure management is a crucial driver for the expansion and domination of the antihypertensive medicines market in diabetic nephropathy market.
Will Ongoing Advancements in Biotechnology and Molecular Diagnostics Drive the Diagnostic Tools Segment?
Ongoing improvements in biotechnology and molecular diagnostics will continue to fuel the diabetic nephropathy diagnostic instruments market. Innovations in these disciplines improve diagnostic tests’ accuracy, sensitivity, and specificity, allowing for earlier and more reliable detection of diabetic nephropathy.
Next-generation sequencing, high-throughput screening, and innovative biomarker development have all improved the ability to detect early illness indications. These technologies enable more precise monitoring of disease development and therapy efficacy, which leads to better patient care.
The development of less invasive and more patient-friendly diagnostic procedures improves patient compliance and simplifies routine screening. Increased investment in R&D, combined with growing awareness among healthcare professionals and patients, further supports the incorporation of new diagnostic technologies into clinical practice, boosting market expansion in the diagnostic tools segment.
Gain Access into Diabetic Nephropathy Market Report Methodology
https://www.verifiedmarketresearch.com/select-licence/?rid=41637
Country/Region Wise Acumens
Will Increasing Awareness About Diabetes Drive the Market in North America?
The diabetic nephropathy market in North America is predicted to grow due to increasing awareness of diabetes. Increasing awareness leads to earlier diagnosis and better care of diabetes, lowering the risk of complications such diabetic nephropathy. Public health campaigns, educational programs and healthcare-related activities all play an important role in distributing diabetes preventive and management information.
This increasing knowledge motivates people to have regular screenings and live healthier lifestyles, which can help delay or avoid the onset of diabetic nephropathy. Also, informed healthcare providers can provide better care and more effective treatment alternatives to their patients.
Furthermore, awareness campaigns frequently result in greater funding and support for research and development of new therapies and technologies, which promotes market innovation. Overall, increasing knowledge of diabetes its complications is a significant driver of the diabetic nephropathy market in North America.
Will Rising Diabetes Prevalence Drive the Market in Asia Pacific Region?
Rising diabetes prevalence is projected to propel the diabetic nephropathy market in Asia-Pacific. The region is seeing a huge increase in diabetes cases as a result of urbanization, sedentary lifestyles, bad diets and an aging population. This rise in diabetes prevalence is directly related to a higher incidence of diabetic nephropathy.
As more people develop diabetes, the need for improved diagnostic and therapeutic options for diabetic nephropathy grows. Improving healthcare infrastructure and increasing government initiatives to treat diabetes will help drive market expansion. Furthermore, growing awareness of diabetes management and consequences promotes early diagnosis and treatment, driving market growth.
Pharmaceutical and biotechnology firms are also focusing on the Asia-Pacific area for clinical trials and product launches, given the enormous patient pool and unmet medical requirements further propelling market growth.
Competitive Landscape
The diabetic nephropathy market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.
Some of the prominent players operating in the diabetic nephropathy market include:
Novartis AG, Merck & Co., Inc., Abbott Laboratories, Sanofi, Novo Nordisk, Eli Lilly and Company, Reata Pharmaceuticals, Inc., Bayer, AGAbbVie, Inc.
Latest Developments
- In November 2023, ProKidney Corp. got approval from the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) for ProAct 1 (REGEN-006) and received scientific advice from the EMA on phase 3 protocols for REACT in diabetic chronic kidney disease.
- In March 2024, Novo Nordisk, a multinational pharmaceutical corporation, revealed the results of the renal outcomes trial | FLOW. In a double-blind experiment, injectable semaglutide 1.0 mg was compared to placebo as an addition to routine therapy for preventing kidney impairment development and reducing the risk of kidney and cardiovascular mortality in type 2 diabetic patients. Chronic Kidney Disease (CKD). The trial showed that semaglutide 1.0 mg was safe and well-tolerated, consistent with earlier studies.
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2018-2031 |
| Growth Rate | CAGR of ~5.4% from 2024 to 2031 |
| Base Year for Valuation | 2023 |
| Historical Period | Historical Period |
| Forecast Period | Forecast Period |
| Quantitative Units | Value in USD Billion |
| Report Coverage | Historical and Forecast Revenue Forecast, Historical and Forecast Volume, Growth Factors, Trends, Competitive Landscape, Key Players, Segmentation Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Players | Novartis AG, Merck & Co., Inc., Abbott Laboratories, Sanofi, Novo Nordisk, Eli Lilly and Company, Reata Pharmaceuticals, Inc., Bayer, AGAbbVie, Inc. |
| Customization | Report customization along with purchase available upon request |
Diabetic Nephropathy Market, By Category
Treatment
- Antihypertensive Drugs
- Diuretics
- Dietary and Lifestyle Modifications
- Antioxidants
Diagnostic Tools
- Biomarker-based Tests
- Imaging Techniques
- Urinalysis
Indication
- Type-1 Diabetes
- Type-2 Diabetes
End-User
- Hospital & Clinics
- Surgical Centers
Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team at Verified Market Research.
Reasons to Purchase this Report:
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
1. Introduction
· Market Definition
· Market Segmentation
· Research Methodology
2. Executive Summary
· Key Findings
· Market Overview
· Market Highlights
3. Market Overview
· Market Size and Growth Potential
· Market Trends
· Market Drivers
· Market Restraints
· Market Opportunities
· Porter’s Five Forces Analysis
4. Diabetic Nephropathy Market, By Treatment Type
• ACE And ARB
• Antihypertensive Drugs
• Diuretics
• Antioxidants
• Dietary and Lifestyle Modifications
5. Diabetic Nephropathy Market, By End-User
• Hospitals and Clinics
• Research and Academic Institutes
• Ambulatory Surgical Centers
6. Diabetic Nephropathy Market, By Diagnostic Tools
• Biomarker-based Tests
• Imaging Techniques
• Urinalysis
7. Regional Analysis
· North America
· United States
· Canada
· Mexico
· Europe
· United Kingdom
· Germany
· France
· Italy
· Asia-Pacific
· China
· Japan
· India
· Australia
· Latin America
· Brazil
· Argentina
· Chile
· Middle East and Africa
· South Africa
· Saudi Arabia
· UAE
8. Market Dynamics
· Market Drivers
· Market Restraints
· Market Opportunities
· Impact of COVID-19 on the Market
9. Competitive Landscape
· Key Players
· Market Share Analysis
10. Company Profiles
• Novartis AG
• Merck & Co., Inc.
• Pfizer Inc.
• Abbott Laboratories
• Sanofi
• Eli Lilly and Company
• AbbVie Inc.
• Reata Pharmaceuticals, Inc.
• Bayer AG
• Mitsubishi Tanabe Pharma Corporation
11. Market Outlook and Opportunities
• Emerging Technologies
• Future Market Trends
• Investment Opportunities
12. Appendix
• List of Abbreviations
• Sources and References
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
